BMRN : BioMarin Pharmaceutical stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2026-01-20 |
|---|---|---|---|---|
| 2026 | $75.42 | $56.3 | $89.58 | 33.94% |
| 2027 | $101.32 | $89.75 | $108.18 | 79.93% |
| 2028 | $106.65 | $102.4 | $109.6 | 89.39% |
| 2029 | $127.03 | $105.77 | $138.65 | 125.58% |
| 2030 | $137.11 | $130.05 | $150.97 | 143.49% |
| 2031 | $157.11 | $151.88 | $165.61 | 179.0% |
| 2032 | $165.65 | $160.69 | $170.29 | 194.17% |
| 2033 | $168.5 | $167.74 | $169.17 | 199.24% |
| 2034 | $160.79 | $147.03 | $167.45 | 185.54% |
| 2035 | $134.51 | $124.44 | $144.99 | 138.88% |
| 2036 | $119.21 | $119.21 | $119.21 | 111.7% |
The 11 Wall Street analysts offering BioMarin Pharmaceutical stock forecast in the last 6 months have average price target of
$86.45 with a high forecast of $119.0 and a low forecast of $55.0.
The average BioMarin Pharmaceutical stock forecast represents a 53.53%
increase from the last price of $56.310001373291.
For BioMarin Pharmaceutical stock forecast for 2026, 11 predictions are offered for each month of 2026 with average BioMarin Pharmaceutical stock
forecast of $75.42, a high forecast of $89.58, and a low forecast of $56.3.
The average BioMarin Pharmaceutical stock forecast 2026 represents a 33.94%
increase from the last price of $56.310001373291.
For BioMarin Pharmaceutical stock forecast for 2027, 12 predictions are offered for each month of 2027 with average BioMarin Pharmaceutical stock
forecast of $101.32, a high forecast of $108.18, and a low forecast of $89.75.
The average BioMarin Pharmaceutical stock forecast 2027 represents a 79.93%
increase from the last price of $56.310001373291.
For BioMarin Pharmaceutical stock forecast for 2029, 12 predictions are offered for each month of 2029 with average BioMarin Pharmaceutical stock
forecast of $127.03, a high forecast of $138.65, and a low forecast of $105.77.
The average BioMarin Pharmaceutical stock forecast 2029 represents a 125.58%
increase from the last price of $56.310001373291.
For BioMarin Pharmaceutical stock forecast for 2031 (5 year), 12 predictions are offered for each month of 2031 with average BioMarin Pharmaceutical stock
forecast of $157.11, a high forecast of $165.61, and a low forecast of $151.88.
The average BioMarin Pharmaceutical stock forecast 2031 represents a 179.0%
increase from the last price of $56.310001373291.
For BioMarin Pharmaceutical stock forecast 2032, 12 predictions are offered for each month of 2032 with average BioMarin Pharmaceutical stock
forecast of $165.65, a high forecast of $170.29, and a low forecast of $160.69.
The average BioMarin Pharmaceutical stock forecast 2032 represents a 194.17%
increase from the last price of $56.310001373291.
For BioMarin Pharmaceutical stock forecast for 2036 (10 year), 1 predictions are offered for each month of 2036 with average BioMarin Pharmaceutical stock
forecast of $119.21, a high forecast of $119.21, and a low forecast of $119.21.
The average BioMarin Pharmaceutical stock forecast 2036 represents a 111.7%
increase from the last price of $56.310001373291.
Please, see more forecasts below.
BMRN : BioMarin Pharmaceutical stock forecast by Wall Street Analysts
The average BioMarin Pharmaceutical stock forecast from last 6 month is $86.45, and this show a -6.01% decrease in average from the prior price target of the each prediction. Also, this average forecast of $86.45 represents a -10.03% decrease from the past average forecast of $96.09, 6 months ago from 11 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-10-28 | Morgan Stanley | $104.0000 | $98.0000 | Overweight |
| 2025-10-28 | Barclays | $86.00 | $80.0000 | Overweight |
| 2025-10-28 | Stifel | $91.0000 | $73.0000 | Buy |
| 2025-10-28 | Wells Fargo | $90.00 | $70.0000 | Overweight |
| 2025-10-28 | Truist Securities | $90.00 | $80.0000 | Buy |
| 2025-10-27 | HC Wainwright & Co. | $60.00 | $55.0000 | Neutral |
| 2025-10-09 | JP Morgan | $116.0000 | $119.0000 | Overweight |
| 2025-09-08 | HC Wainwright & Co. | $60 | Neutral | |
| 2025-08-06 | Guggenheim | $101.0000 | $106.0000 | Buy |
| 2025-08-05 | UBS | $113.00 | $114.0000 | Buy |
| 2025-07-22 | Morgan Stanley | $97.0000 | $96.0000 | Overweight |
| 2025-07-14 | JP Morgan | $108.0000 | $113.0000 | Overweight |
| 2025-05-05 | Goldman Sachs | $124.0000 | $104.0000 | Buy |
| 2025-05-02 | Citigroup | $82.00 | $78.0000 | Neutral |
| 2025-02-24 | Oppenheimer | $98.0000 | Outperform | |
| 2025-02-20 | Scotiabank | $78.00 | $80.0000 | Sector Perform |
| 2025-02-20 | B of A Securities | $99.0000 | $103 | Buy |
| 2025-02-20 | Piper Sandler | $122.00 | $126 | Overweight |
| 2025-02-20 | UBS | $109.0000 | $113.0000 | Buy |
| 2025-02-20 | Cantor Fitzgerald | $90.0000 | $90.0000 | Overweight |
| 2025-02-20 | RBC Capital | $70 | $70.0000 | Sector Perform |
| 2025-02-20 | Citigroup | $81.00 | $82.0000 | Neutral |
BioMarin Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2026-01-22 | $57.42 | 1.97% |
| 2026-01-23 | $58.08 | 1.15% |
| 2026-01-26 | $58.84 | 1.31% |
| 2026-01-27 | $59.33 | 0.84% |
| 2026-01-28 | $59.49 | 0.27% |
BMRN : Long term BioMarin Pharmaceutical stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2026 Feb. is $56.30 , for 2027 Jan. is $89.75 , for 2030 Jan. is $133.64 , for 2031 Jan. is $152.21 , for 2035 Jan. is $144.99 , and for 2036 Jan. is $119.21.
BMRN : BioMarin Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Feb. | $56.30 | -0.02% |
| 2026 Mar. | $58.50 | 3.92% |
| 2026 Apr. | $62.65 | 7.09% |
| 2026 May. | $67.78 | 8.18% |
| 2026 Jun. | $73.23 | 8.04% |
| 2026 Jul. | $78.40 | 7.06% |
| 2026 Aug. | $82.44 | 5.16% |
| 2026 Sep. | $85.21 | 3.36% |
| 2026 Oct. | $87.28 | 2.42% |
| 2026 Nov. | $88.27 | 1.14% |
| 2026 Dec. | $89.58 | 1.49% |
BMRN : BioMarin Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $89.75 | 0.18% |
| 2027 Feb. | $92.80 | 3.40% |
| 2027 Mar. | $95.55 | 2.96% |
| 2027 Apr. | $97.94 | 2.51% |
| 2027 May. | $100.08 | 2.18% |
| 2027 Jun. | $102.01 | 1.93% |
| 2027 Jul. | $103.72 | 1.67% |
| 2027 Aug. | $105.10 | 1.33% |
| 2027 Sep. | $106.16 | 1.01% |
| 2027 Oct. | $106.95 | 0.75% |
| 2027 Nov. | $107.59 | 0.59% |
| 2027 Dec. | $108.18 | 0.55% |
BMRN : BioMarin Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $108.71 | 0.49% |
| 2028 Feb. | $109.20 | 0.46% |
| 2028 Mar. | $109.55 | 0.32% |
| 2028 Apr. | $109.60 | 0.05% |
| 2028 May. | $109.22 | -0.35% |
| 2028 Jun. | $108.45 | -0.71% |
| 2028 Jul. | $107.12 | -1.23% |
| 2028 Aug. | $105.53 | -1.48% |
| 2028 Sep. | $103.89 | -1.55% |
| 2028 Oct. | $102.74 | -1.12% |
| 2028 Nov. | $102.40 | -0.33% |
| 2028 Dec. | $103.34 | 0.92% |
BMRN : BioMarin Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $105.77 | 2.35% |
| 2029 Feb. | $109.35 | 3.39% |
| 2029 Mar. | $113.66 | 3.94% |
| 2029 Apr. | $118.66 | 4.40% |
| 2029 May. | $124.19 | 4.66% |
| 2029 Jun. | $129.87 | 4.57% |
| 2029 Jul. | $134.77 | 3.77% |
| 2029 Aug. | $137.79 | 2.24% |
| 2029 Sep. | $138.65 | 0.63% |
| 2029 Oct. | $138.51 | -0.10% |
| 2029 Nov. | $137.42 | -0.79% |
| 2029 Dec. | $135.68 | -1.26% |
BMRN : BioMarin Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $133.64 | -1.51% |
| 2030 Feb. | $131.81 | -1.37% |
| 2030 Mar. | $130.58 | -0.93% |
| 2030 Apr. | $130.05 | -0.40% |
| 2030 May. | $130.41 | 0.27% |
| 2030 Jun. | $131.79 | 1.06% |
| 2030 Jul. | $134.10 | 1.75% |
| 2030 Aug. | $137.26 | 2.36% |
| 2030 Sep. | $141.08 | 2.78% |
| 2030 Oct. | $145.09 | 2.84% |
| 2030 Nov. | $148.55 | 2.39% |
| 2030 Dec. | $150.97 | 1.62% |
BMRN : BioMarin Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $152.21 | 0.83% |
| 2031 Feb. | $152.49 | 0.18% |
| 2031 Mar. | $152.22 | -0.18% |
| 2031 Apr. | $151.88 | -0.22% |
| 2031 May. | $151.88 | 0.00% |
| 2031 Jun. | $152.74 | 0.56% |
| 2031 Jul. | $155.22 | 1.62% |
| 2031 Aug. | $159.06 | 2.47% |
| 2031 Sep. | $162.35 | 2.07% |
| 2031 Oct. | $164.27 | 1.19% |
| 2031 Nov. | $165.34 | 0.65% |
| 2031 Dec. | $165.61 | 0.16% |
BMRN : BioMarin Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $165.21 | -0.24% |
| 2032 Feb. | $164.19 | -0.62% |
| 2032 Mar. | $162.49 | -1.03% |
| 2032 Apr. | $160.98 | -0.93% |
| 2032 May. | $160.69 | -0.18% |
| 2032 Jun. | $162.13 | 0.90% |
| 2032 Jul. | $165.35 | 1.99% |
| 2032 Aug. | $167.89 | 1.53% |
| 2032 Sep. | $169.81 | 1.14% |
| 2032 Oct. | $170.29 | 0.28% |
| 2032 Nov. | $169.80 | -0.29% |
| 2032 Dec. | $168.96 | -0.49% |
BMRN : BioMarin Pharmaceutical stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $168.26 | -0.41% |
| 2033 Feb. | $167.82 | -0.26% |
| 2033 Mar. | $167.74 | -0.05% |
| 2033 Apr. | $168.14 | 0.24% |
| 2033 May. | $168.63 | 0.29% |
| 2033 Jun. | $168.94 | 0.19% |
| 2033 Jul. | $169.13 | 0.11% |
| 2033 Aug. | $169.17 | 0.02% |
| 2033 Sep. | $169.05 | -0.07% |
| 2033 Oct. | $168.79 | -0.15% |
| 2033 Nov. | $168.41 | -0.22% |
| 2033 Dec. | $167.96 | -0.27% |
BMRN : BioMarin Pharmaceutical stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $167.45 | -0.30% |
| 2034 Feb. | $166.94 | -0.31% |
| 2034 Mar. | $166.44 | -0.30% |
| 2034 Apr. | $165.97 | -0.28% |
| 2034 May. | $165.50 | -0.28% |
| 2034 Jun. | $164.98 | -0.31% |
| 2034 Jul. | $164.04 | -0.57% |
| 2034 Aug. | $161.52 | -1.54% |
| 2034 Sep. | $157.18 | -2.69% |
| 2034 Oct. | $152.86 | -2.74% |
| 2034 Nov. | $149.55 | -2.17% |
| 2034 Dec. | $147.03 | -1.68% |
BMRN : BioMarin Pharmaceutical stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $144.99 | -1.39% |
| 2035 Feb. | $143.29 | -1.17% |
| 2035 Mar. | $141.84 | -1.01% |
| 2035 Apr. | $140.56 | -0.90% |
| 2035 May. | $138.93 | -1.16% |
| 2035 Jun. | $135.69 | -2.33% |
| 2035 Jul. | $131.70 | -2.94% |
| 2035 Aug. | $129.46 | -1.70% |
| 2035 Sep. | $128.46 | -0.77% |
| 2035 Oct. | $127.83 | -0.50% |
| 2035 Nov. | $126.96 | -0.67% |
| 2035 Dec. | $124.44 | -1.99% |
BMRN : BioMarin Pharmaceutical stock forecast for 2036
| Date | Price Target | Change |
|---|---|---|
| 2036 Jan. | $119.21 | -4.20% |
Financial Data for BioMarin Pharmaceutical stock
Frequently Asked Questions about BioMarin Pharmaceutical stock forecast
Is BioMarin Pharmaceutical a good long term stock?
From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2026 Feb. is $56.2995545070068 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2027 Jan. is $89.7455785226448 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2030 Jan. is $133.641674319159 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2031 Jan. is $152.212368187895 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2035 Jan. is $144.986397167262 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2036 Jan. is $119.210332936482
Is BioMarin Pharmaceutical stock overvalued?
BioMarin Pharmaceutical (BMRN) stock is expected to go UP . Therefore, AIPickup would say that BioMarin Pharmaceutical (BMRN) stock is NOT overvalued.
Will BioMarin Pharmaceutical stock price go up?
Yes. The BioMarin Pharmaceutical stock price forecast for 2027 Jan. is $89.7455785226448
Is BioMarin Pharmaceutical stock a good buy now?
Since closing price on 2026-01-20 is $56.310001373291 and forecast for 2027 Jan. is $89.75, BioMarin Pharmaceutical stock is a good 1 year investment.
14 Days Historical Data for BioMarin Pharmaceutical stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| BMRN stock price for 2025-12-30 | $58.99 | $59.89 | $58.87 | $60.07 |
| BMRN stock price for 2025-12-31 | $59.43 | $58.80 | $58.44 | $59.72 |
| BMRN stock price for 2026-01-02 | $59.45 | $59.43 | $58.89 | $59.82 |
| BMRN stock price for 2026-01-05 | $58.87 | $59.15 | $58.38 | $59.60 |
| BMRN stock price for 2026-01-06 | $60.07 | $58.87 | $58.87 | $60.46 |
| BMRN stock price for 2026-01-07 | $61.31 | $60.50 | $60.34 | $61.88 |
| BMRN stock price for 2026-01-08 | $60.35 | $61.00 | $59.80 | $61.28 |
| BMRN stock price for 2026-01-09 | $58.95 | $60.52 | $58.85 | $60.80 |
| BMRN stock price for 2026-01-12 | $57.71 | $58.96 | $57.27 | $59.03 |
| BMRN stock price for 2026-01-13 | $55.20 | $57.82 | $54.36 | $57.95 |
| BMRN stock price for 2026-01-14 | $56.08 | $55.44 | $55.20 | $56.37 |
| BMRN stock price for 2026-01-15 | $55.07 | $56.23 | $54.81 | $56.35 |
| BMRN stock price for 2026-01-16 | $54.59 | $55.00 | $54.58 | $55.23 |
| BMRN stock price for 2026-01-20 | $56.31 | $54.73 | $54.07 | $56.42 |